Close mobile menu×

Tongalp H. Tezel, MD

Expertise in: 
Cancer Care
Board Certifications: 
Ophthalmology
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-9535

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Ophthalmology

Clinical Expertise

  • Cancer Care
  • Detached Retina Repair
  • Retina and Vitreous Surgery
  • Retinal Detachment
  • Retinal Vascular Disorders
  • Macular Hole
  • Diabetic Retinopathy
  • Macular Degeneration
  • Retinal Disorder
  • Retinitis pigmentosa

Education & Training

  • Internship: St Mary's Health Center
  • Residency: Washington University School of Medicine, St. Louis, MO
  • Fellowship: Columbia University College of Physicians and Surgeons

Honors & Awards

  • 2012:  American Academy of Ophthalmology’s Achievement Award
  • 2011:  Alpha Omega Alpha Faculty Membership
  • 2007- Present:  Listed, Best Doctors in America
  • 2006: Patrick O’Connor Award for Excellence in Teaching
  • 2005: The American Society of Retina Specialists’ Honor Award
  • 2004: RPB Career Development Award
  • 2004: Patrick O’Connor Award for Excellence in Teaching
  • 2004: NEI Clinician-Scientist Development Award
  • 2002: Ronald Michels Fellowship Award
  • 2000: Rosenbaum Research Award

About Tongalp Tezel

Tongalp H. Tezel, MD leads the retina service at the Department of Ophthalmology. Dr. Tezel is an internationally known clinician-scientist and a leader in the management of vitreoretinal diseases. He was previously Associate Professor of Ophthalmology and the Kentucky Lions Endowed Chair in the Department of Ophthalmology and Visual Sciences at the University of Louisville.

Dr. Tezel received his medical degree and initial ophthalmology training in Turkey and Denmark before completing his ophthalmology residency at Washington University School of Medicine. He later trained under Dr. Stanley Chang and received his fellowship in vitreoretinal surgery here at Columbia University.

Dr. Tezel's research laboratory focuses on investigating the molecular mechanisms of various retinal diseases. His main research interests include retinal cell transplantation, angiogenesis, pharmacologic vitreolysis, tissue engineering and drug development for the treatment of age-related macular degeneration, and has developed several techniques used for tissue engineering and retinal cell replacement therapies.

Academic Titles

  • Chang Family Professor of Ophthalmology

Administrative Positions

  • Director, Retina Division
  • Director, Vitreoretinal Fellowship Program

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • French
  • German
  • Turkish

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Amida Care

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

MagnaCare

Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
Edward S. Harkness Eye Institute
635 West 165th Street
New York, NY 10032
Primary
2
CD Third Avenue Office
880 Third Avenue
New York, NY 10022
New Patient Appointments:
(212) 305-9535

Research

Dr. Tezel's research laboratory focuses on investigating the molecular mechanisms of various retinal diseases. His main research interests include retinal cell transplantation, angiogenesis, pharmacologic vitreolysis, tissue engineering and drug development for the treatment of age-related macular degeneration, and has developed several techniques used for tissue engineering and retinal cell replacement therapies.